News & Events
Premium Partner Program
An error has occured
to go to the homepage.
16 April 2014. EKF’s New Lactate Scout+ Analyzer Delivers Cutting-Edge Benefits in Sports Science
Lactate testing with hematocrit compensation is ideal for sports medical health checks
20 March 2014. Proposed acquisitions of Selah Genomics, Inc. and DiaSpect Medical AB.
EKF Diagnostics announces that it has entered into a conditional agreement to acquire Selah Genomics, Inc. and DiaSpect Medical AB.a Swedish based manufacturer of point-of-care haemoglobin analysers.
12 March 2014. Acquisition of Separation Technology, Inc.
EKF Diagnostics Holdings plc, announces that it has acquired Separation Technology, Inc. The Florida based manufacturer of in vitro diagnostics devices for the haematology testing market.
17 April 2014. Director Shareholding
EKF Diagnostics Holdings plc (AIM: EKF) announces, in accordance with the rules of the existing unapproved share option scheme, the following options over the Company's ordinary shares, with a nominal value of 1 pence each, were granted today to Paul Foulger, Finance Director.
General Terms of Sale and Delivery
Website designed by atticusdigital